Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Gynaecological Regimens

Published Sort regimens by
GYN Ovarian germ cell tumour - BEP [bleomycin, etoposide and cISplatin] Id: 60221000210103 Published date: Version: 4.0.0
60221000210103
4.0.0
24/08/2026
GYN - pembrolizumab Q3W [flat dosing] Id: 59561000210109 Published date: Version: 1.0.0
59561000210109
1.0.0
19/08/2022
GYN - pembrolizumab Q3W [weight based dosing] Id: 59581000210101 Published date: Version: 1.0.0
59581000210101
1.0.0
19/08/2022
GYN - pembrolizumab Q6W [flat dosing] Id: 59571000210103 Published date: Version: 1.0.0
59571000210103
1.0.0
19/08/2022

Cervical Regimens

Published Sort regimens by
GYN CX Advanced - beVACizumab 15 mg/kg Q3W Id: 506561000210109 Published date: Version: 1.0.0
506561000210109
1.0.0
15/12/2025
GYN CX Advanced - cARBOplatin and PACLItaxel Id: 59531000210100 Published date: Version: 1.0.0
59531000210100
1.0.0
19/08/2022
GYN CX Advanced - cARBOplatin, PACLItaxel and beVACizumab Id: 59541000210108 Published date: Version: 1.0.0
59541000210108
1.0.0
19/08/2022
GYN CX Advanced - cARBOplatin, PACLItaxel and pembrolizumab Id: 506251000210108 Published date: Version: 1.0.0
506251000210108
1.0.0
03/04/2025
GYN CX Advanced - cARBOplatin, PACLItaxel, beVACizumab and pembrolizumab Id: 393731000210102 Published date: Version: 1.0.0
393731000210102
1.0.0
11/10/2024
GYN CX Advanced - cISplatin and PACLItaxel Id: 59731000210108 Published date: Version: 2.0.0
59731000210108
2.0.0
08/03/2026
GYN CX Advanced - cISplatin, PACLItaxel and beVACizumab Id: 274651000210101 Published date: Version: 2.0.0
274651000210101
2.0.0
08/03/2026
GYN CX Advanced - cISplatin, PACLItaxel and pembrolizumab Id: 303441000210103 Published date: Version: 2.0.0
303441000210103
2.0.0
08/03/2026
GYN CX Advanced - cISplatin, PACLItaxel, beVACizumab and pembrolizumab Id: 303451000210100 Published date: Version: 2.0.0
303451000210100
2.0.0
08/03/2026
GYN CX Locally advanced - cARBOplatin and PACLItaxel [Q1W] induction followed by cISplatin [Q1W] chemoradiation [INTERLACE] Id: 506711000210101 Published date: Version: 1.0.0
Components ▾
Part 1: cARBOplatin and PACLItaxel [Q1W] induction Id: 506721000210106 Published date: Version: 0.0.10
Part 2: cISplatin [Q1W] chemoradiation Id: 506731000210108 Published date: Version: 0.0.5
506711000210101
1.0.0
02/03/2026
GYN CX Locally advanced - cARBOplatin [Q1W] chemoradiation Id: 59931000210106 Published date: Version: 1.0.0
59931000210106
1.0.0
20/10/2022
GYN CX Locally advanced - cISplatin [Q1W] chemoradiation Id: 59921000210109 Published date: Version: 3.0.0
59921000210109
3.0.0
07/05/2026
GYN CX Locally advanced - cISplatin [Q1W] chemoradiation and pembrolizumab Id: 506741000210100 Published date: Version: 1.0.0
506741000210100
1.0.0
02/03/2026

Endometrial Regimens

Published Sort regimens by
GYN END Adjuvant - cARBOplatin and PACLItaxel [chemotherapy-only] Id: 60051000210103 Published date: Version: 2.0.0
60051000210103
2.0.0
13/08/2023
GYN END Adjuvant - cISplatin chemoradiation followed by cARBOplatin and PACLItaxel Id: 60071000210106 Published date: Version: 2.0.0
Components ▾
Part 1: cISplatin chemoradiation Id: 60081000210108 Published date: Version: 0.0.5
Part 2: cARBOplatin and PACLItaxel Id: 60091000210105 Published date: Version: 0.0.5
60071000210106
2.0.0
02/10/2023
GYN END Advanced - cARBOplatin and PACLItaxel Id: 59551000210106 Published date: Version: 1.0.0
59551000210106
1.0.0
19/08/2022
GYN END Advanced - cARBOplatin, PACLItaxel and dostarlimab Id: 496491000210105 Published date: Version: 1.0.0
496491000210105
1.0.0
20/01/2025
GYN END Advanced - cARBOplatin, PACLItaxel and pembrolizumab Id: 496481000210108 Published date: Version: 1.0.0
496481000210108
1.0.0
20/01/2025
GYN END Advanced - cARBOplatin, PACLItaxel and trastuzumab Id: 496511000210103 Published date: Version: 1.0.0
496511000210103
1.0.0
21/01/2025
GYN END Advanced - leNVAtinib and pembrolizumab Q3W [flat dosing] Id: 59661000210108 Published date: Version: 1.0.0
59661000210108
1.0.0
23/08/2022
GYN END Advanced - meDROXYPROGESTERone acetate Id: 59771000210105 Published date: Version: 1.0.0
59771000210105
1.0.0
29/08/2022

GTD Regimens

Published Sort regimens by
GYN GTD - daCTINomycin [low risk] Id: 59591000210104 Published date: Version: 1.0.0
59591000210104
1.0.0
23/08/2022
GYN GTD - EMA-CO [etoposide, metHOTREXATe, daCTINomycin - CYCLOPHOSPHamide and vinCRISTine] [high risk] Id: 59911000210104 Published date: Version: 1.0.0
59911000210104
1.0.0
25/07/2025
GYN GTD - EP [etoposide and cISplatin] [very high risk] Id: 59851000210109 Published date: Version: 2.0.0
59851000210109
2.0.0
07/05/2026
GYN GTD - EP-EMA [etoposide, ciSplatin - etoposide, metHOTREXATe and daCTINomycin] [high risk] Id: 60011000210102 Published date: Version: 2.0.0
60011000210102
2.0.0
08/05/2026
GYN GTD - metHOTREXATe [low risk] Id: 59621000210101 Published date: Version: 1.0.0
59621000210101
1.0.0
19/09/2023
GYN GTD - TP-TE [PACLItaxel, cISplatin - PACLItaxel and etoposide] [relapsed or high risk] Id: 60021000210107 Published date: Version: 2.0.0
60021000210107
2.0.0
08/03/2026

Ovarian Regimens

Published Sort regimens by
GYN OV Adjuvant - cARBOplatin [early stage] Id: 59631000210104 Published date: Version: 2.0.0
59631000210104
2.0.0
13/08/2023
GYN OV Adjuvant - cARBOplatin and PACLitaxel [early stage] Id: 59641000210107 Published date: Version: 2.0.0
59641000210107
2.0.0
13/08/2023
GYN OV Advanced - beVACizumab 15 mg/kg Q3W Id: 59651000210105 Published date: Version: 2.0.0
59651000210105
2.0.0
22/10/2026
GYN OV Advanced - beVACizumab 7.5 mg/kg Q3W Id: 59761000210104 Published date: Version: 2.0.0
59761000210104
2.0.0
22/10/2026
GYN OV Advanced - cARBOplatin [primary treatment] Id: 59751000210102 Published date: Version: 1.0.0
59751000210102
1.0.0
29/08/2022
GYN OV Advanced - cARBOplatin and DOCEtaxel Id: 59721000210106 Published date: Version: 2.0.0
59721000210106
2.0.0
13/08/2023
GYN OV Advanced - cARBOplatin and PACLItaxel [Q1W] Id: 59711000210101 Published date: Version: 3.0.0
59711000210101
3.0.0
03/04/2025
GYN OV Advanced - cARBOplatin and PACLitaxel [Q3W] Id: 59701000210103 Published date: Version: 2.0.0
59701000210103
2.0.0
13/08/2023
GYN OV Advanced - cARBOplatin, PACLItaxel and beVACizumab Id: 59691000210103 Published date: Version: 2.0.0
59691000210103
2.0.0
02/10/2023
GYN OV Advanced - niraparib Id: 393741000210105 Published date: Version: 1.0.0
Components ▾
niraparib 200 mg Id: 393751000210108 Published date: Version: 0.0.3
niraparib 300 mg Id: 393761000210106 Published date: Version: 0.0.4
393741000210105
1.0.0
11/10/2024
GYN OV Advanced - olaparib Id: 59671000210102 Published date: Version: 1.0.0
59671000210102
1.0.0
29/08/2022
GYN OV Low grade serous carcinoma - letrozole maintenance Id: 60001000210104 Published date: Version: 1.0.0
60001000210104
1.0.0
20/10/2022
GYN OV Low grade serous carcinoma - tRAMEtinib Id: 506751000210102 Published date: Version: 1.0.0
506751000210102
1.0.0
02/03/2026
GYN OV Recurrent - cARBOplatin Id: 59681000210100 Published date: Version: 1.0.0
59681000210100
1.0.0
29/08/2022
GYN OV Recurrent - cARBOplatin and gemcitabine [day 1 cARBOplatin] Id: 59891000210102 Published date: Version: 2.0.0
59891000210102
2.0.0
08/05/2026
GYN OV Recurrent - cARBOplatin and pegylated liposomal DOXOrubicin hydrochloride Id: 59881000210104 Published date: Version: 1.0.0
59881000210104
1.0.0
28/09/2022
GYN OV Recurrent - cARBOplatin, gemcitabine and beVACizumab Id: 59871000210101 Published date: Version: 2.0.0
59871000210101
2.0.0
08/05/2026
GYN OV Recurrent - cARBOplatin, pegylated liposomal DOXOrubicin hydrochloride and beVACizumab Id: 59861000210107 Published date: Version: 1.0.0
59861000210107
1.0.0
28/09/2022
GYN OV Recurrent - CYCLOPHOSPHamide oral [2/4 dosing] Id: 59991000210107 Published date: Version: 1.0.0
59991000210107
1.0.0
20/10/2022
GYN OV Recurrent - CYCLOPHOSPHamide oral [continuous] Id: 59981000210105 Published date: Version: 1.0.0
59981000210105
1.0.0
20/10/2022
GYN OV Recurrent - etoposide oral Id: 59971000210108 Published date: Version: 1.0.0
59971000210108
1.0.0
20/10/2022
GYN OV Recurrent - gemcitabine Id: 59961000210102 Published date: Version: 1.0.0
59961000210102
1.0.0
20/10/2022
GYN OV Recurrent - PACLitaxel [Q1W] Id: 60201000210106 Published date: Version: 2.0.0
60201000210106
2.0.0
03/04/2025
GYN OV Recurrent - PACLitaxel [Q1W] and beVACizumab Id: 60211000210108 Published date: Version: 2.0.0
60211000210108
2.0.0
03/04/2025
GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride Id: 59951000210100 Published date: Version: 1.0.0
59951000210100
1.0.0
20/10/2022
GYN OV Recurrent - pegylated liposomal DOXOrubicin hydrochloride and beVACizumab Id: 59941000210103 Published date: Version: 2.0.0
59941000210103
2.0.0
24/08/2026
GYN OV Recurrent - topotecan Id: 60061000210100 Published date: Version: 1.0.0
60061000210100
1.0.0
28/10/2022
GYN OV Recurrent - topotecan and beVACizumab Q4W Id: 60031000210109 Published date: Version: 2.0.0
60031000210109
2.0.0
24/08/2026

Vulval Regimens

Published Sort regimens by
GYN VUL Advanced - CARBOplatin [Q1W] chemoradiation Id: 60041000210101 Published date: Version: 1.0.0
60041000210101
1.0.0
28/10/2022
GYN VUL Advanced - ciSplatin [Q1W] chemoradiation Id: 264761000210100 Published date: Version: 2.0.0
264761000210100
2.0.0
07/05/2026